Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …
Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?
FH Messerli, S Bangalore, C Bavishi… - Journal of the American …, 2018 - jacc.org
Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
ECK Li, BS Heran, JM Wright - Cochrane Database of …, 2014 - cochranelibrary.com
Background Angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin
receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood …
receptor blockers (ARBs) are widely prescribed for primary hypertension (systolic blood …
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
DB Matchar, DC McCrory, LA Orlando… - Annals of internal …, 2008 - acpjournals.org
Background: The relative effectiveness of angiotensin-converting enzyme (ACE) inhibitors
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …
and angiotensin II receptor blockers (ARBs) for lowering blood pressure is unknown …
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
BS Heran, MMY Wong, IK Heran… - Cochrane Database of …, 2008 - cochranelibrary.com
Background ACE inhibitors are widely prescribed for hypertension so it is essential to
determine and compare their effects on blood pressure (BP), heart rate and withdrawals due …
determine and compare their effects on blood pressure (BP), heart rate and withdrawals due …
Vascular and cardiac benefits of angiotensin receptor blockers
EL Schiffrin - The American journal of medicine, 2002 - Elsevier
Angiotensin II not only is a vasoconstrictor, but it also affects cell growth and apoptosis,
inflammation, fibrosis, and coagulation. Blockade of the renin-angiotensin system, either …
inflammation, fibrosis, and coagulation. Blockade of the renin-angiotensin system, either …
Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations
Hypertension represents a major common cardiovascular risk factor. Optimal control of high
blood pressure levels is recommended to reduce the global burden of hypertensive …
blood pressure levels is recommended to reduce the global burden of hypertensive …
Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system …
LC Van Vark, M Bertrand, KM Akkerhuis… - European heart …, 2012 - academic.oup.com
Aims Renin–angiotensin–aldosterone system (RAAS) inhibitors are well established for the
reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive …
reduction in cardiovascular morbidity, but their impact on all-cause mortality in hypertensive …
The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases
All national guidelines for the management of hypertension recommend angiotensin
receptor blockers (ARBs) as an initial or add-on antihypertensive therapy. The eight …
receptor blockers (ARBs) as an initial or add-on antihypertensive therapy. The eight …
Angiotensin-converting enzyme inhibitors
NJ Brown, DE Vaughan - Circulation, 1998 - Am Heart Assoc
ACE inhibitors have achieved widespread usage in the treatment of cardiovascular and
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …
renal disease. ACE inhibitors alter the balance between the vasoconstrictive, salt-retentive …